AngioDynamics, Inc. Write off of Deferred Debt Issuance Cost
AngioDynamics, Inc. (ANGO) reported Write off of Deferred Debt Issuance Cost of $900.00 thousand for the 12-month period ending 2024-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:WriteOffOfDeferredDebtIssuanceCost · last filed 2026-07-14
- AngioDynamics, Inc. write off of deferred debt issuance cost for the quarter ending 2024-05-31 was $0.00.
- AngioDynamics, Inc. write off of deferred debt issuance cost for fiscal 2024 was $900.00K.
| Period end | Write off of Deferred Debt Issuance Cost 3 month | Write off of Deferred Debt Issuance Cost 9 month | Write off of Deferred Debt Issuance Cost 12 month |
|---|---|---|---|
| 2024-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $900.00K 10-K · filed 2026-07-14 | |
| 2024-02-29 | $900.00K 10-Q · filed 2024-04-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |